Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $9.02 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.31.
Market Cap
9.02T
Revenue
4.59T
Profits
199.05B
PE Ratio
45.31
Profit Margin
4.34%
Dividend Yield
0.39%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | -2.33% | 2,009,540 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 618.61B | -0.82% | 6,539,673 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 438.31B | -0.73% | 5,780,964 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 385.62B | -1.64% | 3,797,864 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 305.12B | -1.22% | 8,388,465 | 65.77B |
| 6 | NVS | Novartis AG | 281.98B | -0.37% | 1,165,695 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 267.14B | -3.85% | 3,595,055 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 218.14B | 1.23% | 5,554,606 | 50.57B |
| 9 | AMGN | Amgen Inc. | 196.12B | -0.06% | 1,632,648 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 195.86B | 0.45% | 1,233,072 | 45.20B |
| 11 | ABT | Abbott Laboratories | 163.61B | -0.50% | 6,912,954 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 161.19B | -3.72% | 5,934,266 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 144.07B | -1.16% | 1,859,655 | 10.58B |
| 14 | DHR | Danaher Corporation | 140.88B | 1.57% | 3,847,651 | 24.78B |
| 15 | PFE | Pfizer Inc. | 137.76B | -0.33% | 27,507,745 | 63.32B |
| 16 | CVS | CVS Health Corporation | 132.89B | 1.30% | 9,355,913 | 405.62B |
| 17 | SYK | Stryker Corporation | 126.42B | 0.82% | 2,724,625 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 123.19B | -2.24% | 1,423,215 | 12.22B |
| 19 | BMY | Bristol-Myers Squibb Company | 117.58B | -0.62% | 11,203,225 | 48.48B |
| 20 | MDT | Medtronic plc | 107.36B | 1.80% | 7,191,129 | 36.36B |
| 21 | GSK | GSK plc | 104.89B | 0.59% | 2,867,671 | 43.29B |
| 22 | SNY | Sanofi | 104.60B | -0.91% | 2,662,061 | 54.60B |
| 23 | MCK | McKesson Corporation | 94.36B | 1.66% | 491,757 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 90.39B | -0.99% | 779,526 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 90.20B | -0.59% | 1,651,232 | 76.39B |
| 26 | CI | The Cigna Group | 77.63B | 0.57% | 761,537 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.61B | -0.51% | 565,814 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 66.54B | -0.49% | 12,035,198 | 20.61B |
| 29 | COR | Cencora, Inc. | 59.04B | 0.32% | 761,481 | 328.68B |
| 30 | CAH | Cardinal Health, Inc. | 55.23B | 0.87% | 1,904,431 | 250.74B |
| 31 | ARGX | argenx SE | 54.63B | -3.50% | 325,036 | 4.74B |
| 32 | MDLN | Medline Inc. | 53.91B | 0.47% | 3,143,035 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 53.09B | 0.96% | 3,381,396 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 52.42B | -0.30% | 1,503,658 | 28.34B |
| 35 | HUM | Humana Inc. | 47.09B | -1.39% | 1,006,263 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.46B | 0.89% | 612,493 | 4.45B |
| 37 | HLN | Haleon plc | 42.80B | 0.51% | 3,940,688 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 41.87B | 0.72% | 1,048,173 | 22.23B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.89B | -4.49% | 2,538,113 | 4.29B |
| 40 | RVMD | Revolution Medicines, Inc. | 39.73B | -2.22% | 1,355,157 | - |
| 41 | NTRA | Natera, Inc. | 38.66B | -4.22% | 969,458 | 2.50B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 38.37B | -0.45% | 6,638,127 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 37.93B | 0.52% | 2,175,280 | 7.23B |
| 44 | WAT | Waters Corporation | 36.96B | -0.19% | 502,291 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.69B | -0.54% | 527,781 | 16.63B |
| 46 | CNC | Centene Corporation | 33.26B | -0.37% | 1,613,894 | 178.33B |
| 47 | ONC | BeOne Medicines AG | 33.21B | -1.36% | 254,492 | 5.74B |
| 48 | ALC | Alcon Inc. | 32.91B | 1.00% | 1,691,193 | 10.63B |
| 49 | RPRX | Royalty Pharma plc | 32.49B | -2.64% | 2,518,708 | 2.44B |
| 50 | ZTS | Zoetis Inc. | 31.68B | 0.64% | 5,158,048 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 30.88B | 0.22% | 1,486,644 | 3.32B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.43B | - | 2,559,745 | 20.98B |
| 53 | RMD | ResMed Inc. | 29.41B | -2.20% | 1,331,123 | 5.54B |
| 54 | BIIB | Biogen Inc. | 29.40B | 0.12% | 1,111,563 | 9.94B |
| 55 | DXCM | DexCom, Inc. | 28.93B | 2.66% | 3,856,868 | 4.82B |
| 56 | ILMN | Illumina, Inc. | 28.78B | -1.84% | 1,076,260 | 4.39B |
| 57 | MRNA | Moderna, Inc. | 27.09B | -10.83% | 9,167,302 | 2.23B |
| 58 | MTD | Mettler-Toledo International Inc. | 26.19B | 0.63% | 80,254 | 4.09B |
| 59 | PHG | Koninklijke Philips N.V. | 26.19B | 0.51% | 641,615 | 20.34B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.87B | -2.28% | 6,237,586 | 8.26M |
| 61 | INSM | Insmed Incorporated | 25.06B | -2.24% | 2,931,184 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 24.99B | -1.10% | 446,114 | 3.22B |
| 63 | INCY | Incyte Corporation | 23.32B | -1.53% | 1,643,502 | 5.36B |
| 64 | UTHR | United Therapeutics Corporation | 23.22B | -0.98% | 307,778 | 3.17B |
| 65 | BNTX | BioNTech SE | 23.14B | -1.60% | 551,666 | 3.23B |
| 66 | DGX | Quest Diagnostics Incorporated | 22.96B | -0.29% | 430,687 | 11.28B |
| 67 | LH | Labcorp Holdings Inc. | 22.70B | -0.30% | 268,030 | 14.14B |
| 68 | GH | Guardant Health, Inc. | 21.22B | -2.46% | 1,976,502 | 1.08B |
| 69 | STE | STERIS plc | 21.05B | - | 379,361 | 5.94B |
| 70 | VTRS | Viatris Inc. | 18.95B | -0.43% | 7,928,377 | 14.56B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 17.81B | -1.91% | 1,047,433 | 3.10B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 17.67B | 2.36% | 1,543,063 | 8.41B |
| 73 | THC | Tenet Healthcare Corporation | 17.59B | -1.22% | 879,099 | 21.46B |
| 74 | GMAB | Genmab A/S | 17.55B | -2.62% | 4,927,153 | 3.90B |
| 75 | BBIO | BridgeBio Pharma, Inc. | 16.84B | -4.75% | 6,374,991 | 579.96M |
| 76 | ASND | Ascendis Pharma A/S | 16.80B | -1.81% | 375,365 | 998.25M |
| 77 | MEDP | Medpace Holdings, Inc. | 15.37B | 0.51% | 177,536 | 2.68B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 15.32B | -1.25% | 636,248 | 4.44B |
| 79 | DVA | DaVita Inc. | 14.95B | 1.45% | 775,491 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.88B | -0.21% | 1,817,504 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.20B | -1.05% | 3,219,155 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.79B | -0.45% | 1,393,694 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.28B | 0.97% | 532,939 | 8.26B |
| 84 | SNN | Smith & Nephew plc | 12.90B | 0.99% | 1,861,671 | 6.16B |
| 85 | ALGN | Align Technology, Inc. | 12.85B | 0.72% | 619,362 | 4.10B |
| 86 | ICLR | ICON Public Limited Company | 12.85B | -0.62% | 308,538 | 8.27B |
| 87 | FMS | Fresenius Medical Care AG | 12.75B | 0.46% | 283,037 | 22.32B |
| 88 | RVTY | Revvity, Inc. | 12.53B | -0.58% | 929,159 | 2.90B |
| 89 | PEN | Penumbra, Inc. | 12.51B | 0.05% | 121,581 | 1.45B |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.40B | 0.81% | 3,107,655 | 4.89B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.37B | -4.16% | 294,013 | 1.13B |
| 92 | MOH | Molina Healthcare, Inc. | 12.15B | 0.53% | 688,137 | 43.10B |
| 93 | ABVX | ABIVAX Société Anonyme | 12.11B | -0.60% | 837,549 | 5.67M |
| 94 | AXSM | Axsome Therapeutics, Inc. | 12.03B | -6.09% | 804,605 | 708.24M |
| 95 | SMMT | Summit Therapeutics Inc. | 11.84B | -1.49% | 2,724,961 | - |
| 96 | BAX | Baxter International Inc. | 11.68B | 0.71% | 3,102,822 | 11.32B |
| 97 | CYTK | Cytokinetics, Incorporated | 11.52B | -1.39% | 1,759,780 | 105.82M |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 11.43B | -1.42% | 1,528,322 | 3.24B |
| 99 | CRL | Charles River Laboratories International, Inc. | 11.24B | -0.08% | 873,246 | 4.03B |
| 100 | PODD | Insulet Corporation | 11.17B | 1.89% | 723,285 | 2.90B |
| 101 | TECH | Bio-Techne Corporation | 11.11B | 0.21% | 2,938,081 | 1.21B |
| 102 | EHC | Encompass Health Corporation | 10.93B | -0.77% | 1,069,745 | 6.07B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.87B | -5.04% | 2,841,103 | 3.58B |
| 104 | KRYS | Krystal Biotech, Inc. | 10.78B | -1.46% | 363,514 | 417.30M |
| 105 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.76B | -9.05% | 2,952,192 | 622.01M |
| 106 | GMED | Globus Medical, Inc. | 10.60B | 1.92% | 1,228,903 | 3.10B |
| 107 | TEM | Tempus AI, Inc. | 10.46B | -5.32% | 4,382,117 | 1.36B |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.02B | 0.06% | 787,801 | - |
| 109 | CORT | Corcept Therapeutics Incorporated | 9.86B | -1.47% | 1,128,494 | 769.10M |
| 110 | NUVL | Nuvalent, Inc. | 9.83B | 0.06% | 2,057,856 | - |
| 111 | KYMR | Kymera Therapeutics, Inc. | 9.82B | 0.29% | 665,909 | 51.48M |
| 112 | ENSG | The Ensign Group, Inc. | 9.77B | -0.20% | 326,555 | 5.27B |
| 113 | IONS | Ionis Pharmaceuticals, Inc. | 9.63B | -9.37% | 11,605,035 | 1.06B |
| 114 | HSIC | Henry Schein, Inc. | 9.61B | 0.64% | 1,156,509 | 13.38B |
| 115 | UHS | Universal Health Services, Inc. | 9.42B | 0.24% | 355,897 | 17.76B |
| 116 | OSCR | Oscar Health, Inc. | 9.20B | -2.12% | 4,248,027 | 13.30B |
| 117 | BRKR | Bruker Corporation | 9.14B | -0.86% | 1,150,068 | 3.46B |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 9.06B | -2.44% | 398,571 | 7.46M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 9.04B | -3.08% | 1,465,870 | 1.51B |
| 120 | GKOS | Glaukos Corporation | 8.97B | -1.52% | 672,327 | 551.35M |
| 121 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.81B | -0.05% | 7,355,510 | 18.07M |
| 122 | ALKS | Alkermes plc | 8.66B | -3.42% | 1,691,741 | 1.56B |
| 123 | IBRX | ImmunityBio, Inc. | 8.61B | -7.33% | 12,851,546 | 140.98M |
| 124 | SYRE | Spyre Therapeutics, Inc. | 8.59B | -1.02% | 778,881 | - |
| 125 | QGEN | Qiagen N.V. | 8.58B | -1.14% | 3,243,795 | 2.10B |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 8.45B | -4.52% | 954,566 | 74.06M |
| 127 | PCVX | Vaxcyte, Inc. | 8.41B | -2.71% | 623,949 | - |
| 128 | IMVT | Immunovant, Inc. | 8.15B | -3.36% | 1,095,102 | - |
| 129 | RGEN | Repligen Corporation | 8.14B | 0.21% | 476,012 | 763.34M |
| 130 | TGTX | TG Therapeutics, Inc. | 8.10B | -3.28% | 1,230,096 | 700.35M |
| 131 | ATR | AptarGroup, Inc. | 8.01B | 0.87% | 385,176 | 3.87B |
| 132 | HIMS | Hims & Hers Health, Inc. | 7.96B | -3.02% | 11,833,014 | 2.37B |
| 133 | BIO | Bio-Rad Laboratories, Inc. | 7.92B | -0.39% | 204,531 | 2.59B |
| 134 | HQY | HealthEquity, Inc. | 7.89B | -0.43% | 623,190 | 1.34B |
| 135 | MIRM | Mirum Pharmaceuticals, Inc. | 7.45B | -4.36% | 539,112 | 569.61M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.43B | -6.13% | 505,896 | 217.17M |
| 137 | AVTR | Avantor, Inc. | 7.09B | -1.14% | 6,654,968 | 6.55B |
| 138 | PTCT | PTC Therapeutics, Inc. | 7.04B | -5.25% | 1,049,034 | 827.11M |
| 139 | LQDA | Liquidia Corporation | 6.93B | -4.32% | 1,166,132 | 288.07M |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.88B | -0.33% | 942,438 | 1.55B |
| 141 | HNGE | Hinge Health, Inc. | 6.87B | -1.25% | 1,176,307 | 646.34M |
| 142 | PACS | PACS Group, Inc. | 6.84B | -1.37% | 553,290 | 5.43B |
| 143 | SRRK | Scholar Rock Holding Corporation | 6.80B | -2.12% | 828,788 | - |
| 144 | XENE | Xenon Pharmaceuticals Inc. | 6.66B | -2.87% | 1,535,682 | 7.50M |
| 145 | COGT | Cogent Biosciences, Inc. | 6.64B | -4.05% | 2,051,929 | - |
| 146 | CGON | CG Oncology, Inc. | 6.64B | 2.62% | 1,042,659 | 5.07M |
| 147 | CHE | Chemed Corporation | 6.46B | -0.38% | 123,115 | 2.54B |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.27B | -1.97% | 148,567 | 274.48M |
| 149 | DFTX | Definium Therapeutics, Inc. | 6.25B | -2.85% | 2,554,628 | - |
| 150 | GRFS | Grifols, S.A. | 6.16B | -0.27% | 523,306 | 8.58B |
| 151 | TFX | Teleflex Incorporated | 6.01B | 1.26% | 529,473 | 2.13B |
| 152 | BLTE | Belite Bio, Inc | 5.87B | -2.55% | 153,709 | - |
| 153 | BLLN | BillionToOne, Inc. | 5.83B | -0.94% | 797,698 | 354.54M |
| 154 | BLCO | Bausch + Lomb Corporation | 5.79B | -2.99% | 256,974 | 5.21B |
| 155 | ERAS | Erasca, Inc. | 5.76B | -3.39% | 3,017,884 | - |
| 156 | TWST | Twist Bioscience Corporation | 5.64B | -3.24% | 1,352,195 | 409.48M |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.43B | -0.06% | 1,733,358 | 3.05B |
| 158 | TXG | 10x Genomics, Inc. | 5.42B | -0.86% | 2,832,682 | 638.78M |
| 159 | STVN | Stevanato Group S.p.A. | 5.35B | -0.81% | 353,450 | 1.39B |
| 160 | DNTH | Dianthus Therapeutics, Inc. | 5.34B | -2.43% | 842,583 | 1.34M |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.26B | -3.22% | 1,247,315 | 536.20M |
| 162 | SHC | Sotera Health Company | 5.25B | 0.16% | 2,304,822 | 1.19B |
| 163 | CELC | Celcuity Inc. | 5.25B | -5.22% | 698,625 | - |
| 164 | LEGN | Legend Biotech Corporation | 5.24B | -1.10% | 1,343,006 | 1.14B |
| 165 | ORKA | Oruka Therapeutics, Inc. | 5.23B | -1.68% | 502,966 | - |
| 166 | RDNT | RadNet, Inc. | 5.16B | -0.52% | 376,123 | 2.14B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.15B | -5.31% | 2,072,387 | 4.10M |
| 168 | MANE | Veradermics, Incorporated | 5.00B | -4.25% | 350,821 | - |
| 169 | INDV | Indivior Pharmaceuticals, Inc. | 4.94B | -1.94% | 1,260,190 | 1.29B |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.89B | -6.08% | 1,067,990 | - |
| 171 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.88B | -2.97% | 443,078 | 754.05M |
| 172 | CAI | Caris Life Sciences, Inc. | 4.80B | -4.92% | 2,257,882 | 907.29M |
| 173 | VCYT | Veracyte, Inc. | 4.55B | -3.93% | 757,185 | 541.74M |
| 174 | LIVN | LivaNova PLC | 4.54B | 0.05% | 452,293 | 1.43B |
| 175 | VKTX | Viking Therapeutics, Inc. | 4.51B | -5.54% | 2,158,061 | - |
| 176 | TNGX | Tango Therapeutics, Inc. | 4.49B | 1.77% | 3,020,866 | 56.99M |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.49B | -0.72% | 1,380,932 | 1.10B |
| 178 | MMSI | Merit Medical Systems, Inc. | 4.38B | 2.77% | 739,639 | 1.54B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.36B | -3.59% | 3,188,036 | 10.68M |
| 180 | WAY | Waystar Holding Corp. | 4.30B | -3.24% | 1,463,996 | 1.16B |
| 181 | MMED | MiniMed Group, Inc. | 4.29B | 1.59% | 833,143 | 3.10B |
| 182 | NVST | Envista Holdings Corporation | 4.22B | 0.58% | 3,757,899 | 2.81B |
| 183 | LFST | LifeStance Health Group, Inc. | 4.15B | -0.88% | 2,908,901 | 1.49B |
| 184 | NAMS | NewAmsterdam Pharma Company N.V. | 4.12B | -1.84% | 564,164 | 22.57M |
| 185 | ALHC | Alignment Healthcare, Inc. | 4.10B | -5.71% | 3,946,544 | 4.26B |
| 186 | DNLI | Denali Therapeutics Inc. | 4.08B | -5.62% | 1,396,861 | - |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 4.04B | 0.48% | 793,921 | 2.23B |
| 188 | DOCS | Doximity, Inc. | 3.98B | -1.09% | 1,494,001 | 644.86M |
| 189 | PBLS | Parabilis Medicines, Inc. | 3.89B | 0.69% | 690,363 | - |
| 190 | DYN | Dyne Therapeutics, Inc. | 3.87B | -3.50% | 1,514,764 | - |
| 191 | ICUI | ICU Medical, Inc. | 3.86B | -1.34% | 200,254 | 2.16B |
| 192 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | - | 1,346,495 | 596.96M |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.84B | -5.43% | 186,392 | 803.79M |
| 194 | IRTC | iRhythm Holdings, Inc. | 3.82B | -1.51% | 478,492 | 787.85M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.79B | -3.23% | 736,850 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.64B | -3.47% | 648,142 | 236.00M |
| 197 | ALMS | Alumis Inc. | 3.61B | -6.57% | 930,489 | 8.40M |
| 198 | ELVN | Enliven Therapeutics, Inc. | 3.57B | -2.09% | 623,676 | - |
| 199 | WRBY | Warby Parker Inc. | 3.56B | -0.92% | 1,714,500 | 890.57M |
| 200 | OGN | Organon & Co. | 3.55B | 0.22% | 2,873,475 | 6.16B |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.52B | -0.78% | 677,503 | 225.27M |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 3.47B | -3.61% | 1,571,937 | 415.62M |
| 203 | PRVA | Privia Health Group, Inc. | 3.46B | -1.01% | 820,543 | 2.25B |
| 204 | HAE | Haemonetics Corporation | 3.46B | 1.59% | 456,265 | 1.33B |
| 205 | BKD | Brookdale Senior Living Inc. | 3.44B | -5.69% | 11,734,656 | 3.00B |
| 206 | OPCH | Option Care Health, Inc. | 3.39B | -0.46% | 1,802,965 | 5.67B |
| 207 | ADPT | Adaptive Biotechnologies Corporation | 3.37B | -3.39% | 1,907,792 | 295.41M |
| 208 | RARE | Ultragenyx Pharmaceutical Inc. | 3.32B | -2.28% | 1,578,085 | 670.00M |
| 209 | NHC | National HealthCare Corporation | 3.29B | -1.77% | 109,525 | 1.53B |
| 210 | BEAM | Beam Therapeutics Inc. | 3.25B | -8.77% | 2,634,103 | 164.01M |
| 211 | ITGR | Integer Holdings Corporation | 3.18B | 1.88% | 152,811 | 1.86B |
| 212 | GRAL | GRAIL, Inc. | 3.09B | -5.00% | 509,860 | 156.12M |
| 213 | CLDX | Celldex Therapeutics, Inc. | 3.07B | 0.33% | 693,940 | 865.00K |
| 214 | VERA | Vera Therapeutics, Inc. | 3.01B | -1.06% | 2,849,126 | - |
| 215 | QURE | uniQure N.V. | 2.93B | -4.16% | 1,139,885 | 18.09M |
| 216 | IRON | Disc Medicine, Inc. | 2.93B | -2.98% | 324,578 | - |
| 217 | RGC | Regencell Bioscience Holdings Limited | 2.91B | -3.13% | 331,145 | - |
| 218 | MBX | MBX Biosciences, Inc. | 2.91B | -7.09% | 851,868 | - |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.88B | -0.38% | 2,966,473 | 3.37B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.81B | -0.59% | 1,126,231 | 776.83M |
| 221 | KLRA | Kailera Therapeutics, Inc. | 2.68B | -1.57% | 558,281 | - |
| 222 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.66B | -2.52% | 3,359,350 | 885.72M |
| 223 | IMNM | Immunome, Inc. | 2.64B | -3.39% | 868,183 | 4.02M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.59B | -0.24% | 278,242 | 1.46B |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.59B | -0.83% | 271,508 | 229.58M |
| 226 | KOD | Kodiak Sciences Inc. | 2.58B | 3.07% | 996,539 | - |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.53B | -3.04% | 1,027,147 | - |
| 228 | SLS | SELLAS Life Sciences Group, Inc. | 2.51B | -5.55% | 6,398,593 | - |
| 229 | MLYS | Mineralys Therapeutics, Inc. | 2.50B | -2.00% | 727,682 | - |
| 230 | TARS | Tarsus Pharmaceuticals, Inc. | 2.50B | -9.35% | 2,367,148 | 535.08M |
| 231 | TMDX | TransMedics Group, Inc. | 2.46B | -1.33% | 447,162 | 635.89M |
| 232 | XRAY | DENTSPLY SIRONA Inc. | 2.46B | 3.11% | 4,689,255 | 3.68B |
| 233 | AGIO | Agios Pharmaceuticals, Inc. | 2.45B | -3.65% | 1,114,794 | 66.05M |
| 234 | PHVS | Pharvaris N.V. | 2.45B | -2.47% | 639,255 | - |
| 235 | PGNY | Progyny, Inc. | 2.40B | -1.35% | 990,141 | 1.29B |
| 236 | VCEL | Vericel Corporation | 2.40B | -2.71% | 451,850 | 292.09M |
| 237 | NRIX | Nurix Therapeutics, Inc. | 2.39B | -6.60% | 1,554,089 | 36.77M |
| 238 | NKTR | Nektar Therapeutics | 2.38B | -3.51% | 786,177 | 55.63M |
| 239 | LMAT | LeMaitre Vascular, Inc. | 2.35B | 0.33% | 311,458 | 256.28M |
| 240 | BHVN | Biohaven Ltd. | 2.34B | -7.39% | 1,689,058 | - |
| 241 | CLOV | Clover Health Investments, Corp. | 2.34B | -5.13% | 6,003,929 | 2.21B |
| 242 | ASTH | Astrana Health, Inc. | 2.32B | 0.14% | 350,068 | 3.53B |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.32B | 0.87% | 263,423 | 1.09B |
| 244 | HTFL | HeartFlow, Inc. | 2.30B | -3.61% | 923,956 | 191.42M |
| 245 | ZLAB | Zai Lab Limited | 2.30B | 2.55% | 1,189,829 | 453.28M |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.23B | -3.23% | 1,875,626 | 52.04M |
| 247 | KARD | Kardigan, Inc. | 2.20B | 0.76% | 338,717 | - |
| 248 | VRDN | Viridian Therapeutics, Inc. | 2.18B | -2.28% | 1,431,508 | 70.92M |
| 249 | AXGN | Axogen, Inc. | 2.16B | -6.97% | 1,948,799 | 238.11M |
| 250 | HRMY | Harmony Biosciences Holdings, Inc. | 2.13B | -3.59% | 668,808 | 899.11M |
| 251 | SGRY | Surgery Partners, Inc. | 2.13B | -2.21% | 858,811 | 3.34B |
| 252 | AVAH | Aveanna Healthcare Holdings Inc. | 2.11B | -1.22% | 1,746,374 | 2.52B |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.11B | -2.41% | 436,711 | 1.93B |
| 254 | ADMA | ADMA Biologics, Inc. | 2.10B | -2.05% | 2,343,235 | 509.86M |
| 255 | NEOG | Neogen Corporation | 2.09B | -1.33% | 1,571,285 | 870.56M |
| 256 | SNDX | Syndax Pharmaceuticals, Inc. | 2.09B | -4.95% | 2,100,756 | 217.17M |
| 257 | BFLY | Butterfly Network, Inc. | 2.09B | -0.50% | 5,375,441 | 102.92M |
| 258 | ABCL | AbCellera Biologics Inc. | 2.08B | -6.72% | 7,278,666 | 79.21M |
| 259 | PVLA | Palvella Therapeutics, Inc. | 2.08B | -4.16% | 214,942 | - |
| 260 | NBTX | Nanobiotix S.A. | 2.06B | 2.88% | 119,851 | 38.27M |
| 261 | SION | Sionna Therapeutics, Inc. | 2.04B | 0.78% | 370,997 | - |
| 262 | OMCL | Omnicell, Inc. | 2.04B | -1.47% | 435,044 | 1.23B |
| 263 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -4.88% | 1,023,505 | 298.30M |
| 264 | TSHA | Taysha Gene Therapies, Inc. | 2.03B | -3.50% | 2,850,250 | 7.47M |
| 265 | NUVB | Nuvation Bio Inc. | 2.02B | -4.91% | 5,392,858 | 143.05M |
| 266 | MESO | Mesoblast Limited | 2.02B | 4.11% | 292,515 | 65.38M |
| 267 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | -7.65% | 2,601,510 | 2.18B |
| 268 | RAPP | Rapport Therapeutics, Inc. | 2.00B | -0.71% | 435,479 | 20.00M |
| 269 | NTLA | Intellia Therapeutics, Inc. | 1.99B | -7.93% | 6,174,119 | 66.09M |
| 270 | LKFT | Lakefront Biotherapeutics NV | 1.98B | -1.05% | 136,739 | 1.20B |
| 271 | ADUS | Addus HomeCare Corporation | 1.98B | -1.38% | 220,351 | 1.45B |
| 272 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.98B | -3.32% | 1,069,701 | -665.00K |
| 273 | ALMR | Alamar Biosciences, Inc. | 1.97B | 7.33% | 246,937 | 87.16M |
| 274 | ANAB | AnaptysBio, Inc. | 1.97B | -0.30% | 400,960 | 232.39M |
| 275 | STOK | Stoke Therapeutics, Inc. | 1.95B | -4.42% | 614,856 | 32.08M |
| 276 | WGS | GeneDx Holdings Corp. | 1.95B | -5.40% | 643,813 | 442.68M |
| 277 | TYRA | Tyra Biosciences, Inc. | 1.95B | -0.79% | 1,002,225 | - |
| 278 | GLUE | Monte Rosa Therapeutics, Inc. | 1.95B | -6.04% | 1,718,268 | 42.95M |
| 279 | AGL | agilon health, inc. | 1.92B | -0.71% | 206,260 | 5.82B |
| 280 | HCM | HUTCHMED (China) Limited | 1.90B | 0.82% | 37,482 | 548.51M |
| 281 | ATAI | AtaiBeckley Inc. | 1.90B | -3.00% | 7,997,773 | 3.49M |
| 282 | BCAX | Bicara Therapeutics Inc. | 1.90B | -2.59% | 584,430 | - |
| 283 | PGEN | Precigen, Inc. | 1.90B | -3.80% | 3,455,391 | 31.60M |
| 284 | RXRX | Recursion Pharmaceuticals, Inc. | 1.89B | -5.32% | 20,775,434 | 66.41M |
| 285 | IOVA | Iovance Biotherapeutics, Inc. | 1.89B | -3.20% | 9,920,650 | 285.61M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.89B | -0.32% | 584,383 | 367.34M |
| 287 | NVCR | NovoCure Limited | 1.89B | -5.73% | 1,948,445 | 674.41M |
| 288 | URGN | UroGen Pharma Ltd. | 1.88B | -4.15% | 1,281,162 | 140.49M |
| 289 | ZYME | Zymeworks Inc. | 1.85B | -4.40% | 423,737 | 81.26M |
| 290 | CMPS | COMPASS Pathways plc | 1.84B | 0.29% | 4,187,548 | - |
| 291 | NEO | NeoGenomics, Inc. | 1.84B | -4.21% | 1,377,837 | 745.97M |
| 292 | GENB | Generate Biomedicines, Inc. | 1.84B | -8.87% | 828,947 | 30.30M |
| 293 | UFPT | UFP Technologies, Inc. | 1.83B | -5.13% | 281,586 | 608.85M |
| 294 | PLSE | Pulse Biosciences, Inc. | 1.82B | -3.49% | 257,581 | 751.00K |
| 295 | GHRS | GH Research PLC | 1.82B | -2.54% | 128,431 | - |
| 296 | ZBIO | Zenas BioPharma, Inc. | 1.81B | -2.34% | 959,988 | 10.00M |
| 297 | ABSI | Absci Corporation | 1.80B | -7.59% | 4,695,822 | 1.84M |
| 298 | BHC | Bausch Health Companies Inc. | 1.79B | -1.65% | 1,367,204 | 10.53B |
| 299 | MPLT | MapLight Therapeutics, Inc. | 1.78B | -1.21% | 1,183,970 | - |
| 300 | COAG | Hemab Therapeutics Holdings, Inc. | 1.78B | 2.23% | 210,393 | - |
| 301 | DMRA | Damora Therapeutics, Inc. | 1.76B | -7.31% | 312,623 | - |
| 302 | ANIP | ANI Pharmaceuticals, Inc. | 1.74B | -2.04% | 186,509 | 923.71M |
| 303 | ATRC | AtriCure, Inc. | 1.74B | -0.81% | 531,511 | 552.16M |
| 304 | AAPG | Ascentage Pharma Group International | 1.71B | 5.66% | 3,577 | 82.08M |
| 305 | MAZE | Maze Therapeutics, Inc. | 1.69B | -5.71% | 789,762 | 20.00M |
| 306 | MLTX | MoonLake Immunotherapeutics | 1.68B | 2.16% | 1,939,621 | - |
| 307 | FTRE | Fortrea Holdings Inc. | 1.68B | 0.51% | 832,038 | 2.71B |
| 308 | VIR | Vir Biotechnology, Inc. | 1.68B | -3.68% | 1,676,892 | 65.50M |
| 309 | TDOC | Teladoc Health, Inc. | 1.68B | 0.76% | 2,040,044 | 2.51B |
| 310 | TRLV | Trulieve Cannabis Corp. | 1.66B | -2.49% | 1,415,476 | 1.17B |
| 311 | INVA | Innoviva, Inc. | 1.64B | 0.18% | 2,676,231 | 420.69M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.63B | -1.41% | 559,511 | 1.85B |
| 313 | IMCR | Immunocore Holdings plc | 1.63B | -3.42% | 410,617 | 412.81M |
| 314 | SEPN | Septerna, Inc. | 1.62B | -5.05% | 378,159 | 72.26M |
| 315 | HROW | Harrow, Inc. | 1.58B | -1.05% | 407,752 | 268.68M |
| 316 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.57B | 2.01% | 4,388,990 | 204.73M |
| 317 | AVBP | ArriVent BioPharma, Inc. | 1.57B | 0.06% | 436,615 | - |
| 318 | INNV | InnovAge Holding Corp. | 1.56B | -3.11% | 202,248 | 949.17M |
| 319 | AKTS | Aktis Oncology, Inc. | 1.54B | -1.90% | 487,196 | 8.28M |
| 320 | NVAX | Novavax, Inc. | 1.53B | -0.74% | 5,095,637 | 596.34M |
| 321 | SVRA | Savara Inc. | 1.53B | -4.13% | 1,720,221 | - |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.52B | -2.62% | 454,384 | 83.72M |
| 323 | INSP | Inspire Medical Systems, Inc. | 1.49B | 0.47% | 1,052,865 | 915.25M |
| 324 | ENOV | Enovis Corporation | 1.48B | 2.10% | 768,242 | 2.28B |
| 325 | PSNL | Personalis, Inc. | 1.47B | -3.96% | 3,787,143 | 64.52M |
| 326 | ATEC | Alphatec Holdings, Inc. | 1.47B | 0.74% | 1,460,814 | 787.08M |
| 327 | CDNA | CareDx, Inc. | 1.47B | -2.06% | 665,778 | 412.82M |
| 328 | IART | Integra LifeSciences Holdings Corporation | 1.46B | 2.18% | 951,869 | 1.64B |
| 329 | ARDT | Ardent Health, Inc. | 1.44B | -0.10% | 416,759 | 6.43B |
| 330 | XERS | Xeris Biopharma Holdings, Inc. | 1.44B | -3.25% | 1,525,618 | 314.85M |
| 331 | PRGO | Perrigo Company plc | 1.41B | -1.83% | 3,393,800 | 4.18B |
| 332 | PNTG | The Pennant Group, Inc. | 1.41B | 0.10% | 285,576 | 1.02B |
| 333 | OMDA | Omada Health, Inc. | 1.38B | -1.15% | 734,639 | 283.30M |
| 334 | STAA | STAAR Surgical Company | 1.38B | -0.75% | 368,374 | 290.38M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.38B | -0.18% | 460,738 | 101.66M |
| 336 | INBX | Inhibrx Biosciences, Inc. | 1.36B | -10.44% | 369,466 | 1.30M |
| 337 | AHCO | AdaptHealth Corp. | 1.36B | 0.59% | 1,117,167 | 3.29B |
| 338 | IMTX | Immatics N.V. | 1.32B | -2.81% | 264,070 | 43.00M |
| 339 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | -3.27% | 1,207,798 | - |
| 340 | ARDX | Ardelyx, Inc. | 1.30B | -1.86% | 2,335,836 | 427.68M |
| 341 | AHG | Akso Health Group | 1.30B | 2.01% | 24,532 | 14.84M |
| 342 | PAHC | Phibro Animal Health Corporation | 1.30B | -0.96% | 450,612 | 1.50B |
| 343 | NUTX | Nutex Health Inc. | 1.27B | 0.30% | 86,557 | 879.95M |
| 344 | TRAX | First Tracks Biotherapeutics, Inc. | 1.26B | 11.85% | 1,919,413 | - |
| 345 | MNKD | MannKind Corporation | 1.26B | -1.21% | 3,406,093 | 360.78M |
| 346 | AMN | AMN Healthcare Services, Inc. | 1.26B | 2.63% | 728,595 | 3.42B |
| 347 | QDEL | QuidelOrtho Corporation | 1.25B | 4.76% | 1,278,521 | 2.66B |
| 348 | CAPR | Capricor Therapeutics, Inc. | 1.25B | -4.40% | 1,226,721 | 11.13M |
| 349 | AVLN | Avalyn Pharma Inc. | 1.24B | -2.97% | 321,866 | - |
| 350 | JBIO | Jade Biosciences, Inc. | 1.24B | -6.81% | 1,413,153 | - |
| 351 | IRMD | IRADIMED CORPORATION | 1.24B | -0.86% | 88,906 | 86.28M |
| 352 | MGTX | MeiraGTx Holdings plc | 1.24B | -3.95% | 735,732 | 79.76M |
| 353 | EYPT | EyePoint, Inc. | 1.23B | -0.81% | 1,638,975 | 7.61M |
| 354 | SDGR | Schrödinger, Inc. | 1.23B | -1.79% | 1,094,878 | 254.91M |
| 355 | WVE | Wave Life Sciences Ltd. | 1.20B | -0.95% | 3,550,065 | 71.80M |
| 356 | GMRS | GMR Solutions Inc. | 1.20B | -1.72% | 512,458 | 5.83B |
| 357 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | 5.77% | 1,229,891 | 322.02M |
| 358 | XNCR | Xencor, Inc. | 1.18B | -1.64% | 544,648 | 97.36M |
| 359 | ALVO | Alvotech | 1.17B | -1.20% | 397,680 | 562.04M |
| 360 | AORT | Artivion, Inc. | 1.17B | -0.08% | 333,270 | 458.69M |
| 361 | AZTA | Azenta, Inc. | 1.17B | -0.24% | 544,665 | 596.48M |
| 362 | AVNS | Avanos Medical, Inc. | 1.17B | -0.04% | 261,689 | 715.90M |
| 363 | CNMD | CONMED Corporation | 1.16B | 4.88% | 1,059,130 | 1.37B |
| 364 | SPTX | Seaport Therapeutics, Inc. | 1.16B | 5.22% | 76,158 | - |
| 365 | SANA | Sana Biotechnology, Inc. | 1.15B | -2.04% | 2,904,836 | - |
| 366 | LMRI | Lumexa Imaging Holdings, Inc. | 1.15B | -1.48% | 328,445 | 1.03B |
| 367 | DRTS | Alpha Tau Medical Ltd. | 1.15B | -2.08% | 640,360 | - |
| 368 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | -1.62% | 297,616 | 796.33M |
| 369 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | -0.82% | 898,260 | - |
| 370 | CGEM | Cullinan Therapeutics, Inc. | 1.11B | -1.36% | 684,711 | - |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.10B | -1.24% | 189,570 | 787.69M |
| 372 | BIOA | BioAge Labs, Inc. | 1.08B | -2.21% | 704,392 | 10.32M |
| 373 | FBRX | Forte Biosciences, Inc. | 1.07B | 19.67% | 3,186,095 | - |
| 374 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | 0.26% | 1,321,344 | 1.03B |
| 375 | CERT | Certara, Inc. | 1.05B | -0.29% | 5,220,740 | 419.75M |
| 376 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | -3.01% | 927,009 | - |
| 377 | VOR | Vor Biopharma Inc. | 1.04B | -3.09% | 2,184,946 | - |
| 378 | SLDB | Solid Biosciences Inc. | 1.03B | -6.46% | 1,472,640 | - |
| 379 | CRON | Cronos Group Inc. | 1.03B | -1.08% | 369,371 | 159.54M |
| 380 | OPK | OPKO Health, Inc. | 1.02B | -2.88% | 2,060,929 | 581.12M |
| 381 | KURA | Kura Oncology, Inc. | 1.02B | -5.22% | 1,338,763 | 71.64M |
| 382 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -3.71% | 852,798 | 59.00K |
| 383 | IVA | Inventiva S.A. | 1.01B | -5.08% | 582,528 | 7.94M |
| 384 | EVO | Evotec SE | 1.01B | -1.94% | 31,015 | 859.03M |
| 385 | GLAS | Glass House Brands Inc. | 1.00B | 1.72% | 207,893 | 177.68M |
| 386 | ETON | Eton Pharmaceuticals, Inc. | 1.00B | -1.93% | 250,795 | 86.93M |
| 387 | PCRX | Pacira BioSciences, Inc. | 1.00B | -0.08% | 365,208 | 734.86M |
| 388 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | 3.70% | 2,324,784 | 204.89M |
| 389 | JANX | Janux Therapeutics, Inc. | 1.00B | -2.09% | 832,641 | 13.73M |
| 390 | GDRX | GoodRx Holdings, Inc. | 999.09M | 0.34% | 717,704 | 787.89M |
| 391 | BVS | Bioventus Inc. | 992.39M | -2.78% | 634,017 | 576.30M |
| 392 | LXRX | Lexicon Pharmaceuticals, Inc. | 986.12M | -1.33% | 2,001,171 | 69.64M |
| 393 | PHAR | Pharming Group N.V. | 970.52M | -1.28% | 13,764 | 369.49M |
| 394 | INMD | InMode Ltd. | 968.12M | 1.80% | 823,376 | 374.64M |
| 395 | DBVT | DBV Technologies S.A. | 964.84M | 2.55% | 151,098 | 5.74M |
| 396 | GERN | Geron Corporation | 962.28M | -3.85% | 10,348,868 | 196.12M |
| 397 | AVR | Anteris Technologies Global Corp. | 951.03M | 2.95% | 695,044 | 1.85M |
| 398 | ANNX | Annexon, Inc. | 950.29M | -2.36% | 2,736,831 | - |
| 399 | DSGN | Design Therapeutics, Inc. | 948.72M | -1.49% | 836,764 | - |
| 400 | ABUS | Arbutus Biopharma Corporation | 948.18M | -6.61% | 2,950,552 | 191.45M |
| 401 | LBRX | LB Pharmaceuticals Inc | 944.90M | -2.34% | 186,440 | - |
| 402 | FTH | Faeth Therapeutics, Inc. | 932.16M | 11.12% | 238,098 | - |
| 403 | ANRO | Alto Neuroscience, Inc. | 929.29M | -4.20% | 457,426 | - |
| 404 | REPL | Replimune Group, Inc. | 922.56M | -1.08% | 2,304,258 | - |
| 405 | TENX | Tenax Therapeutics, Inc. | 896.66M | -4.20% | 1,048,512 | - |
| 406 | TBPH | Theravance Biopharma, Inc. | 877.45M | -0.29% | 868,515 | 109.78M |
| 407 | TALK | Talkspace, Inc. | 876.09M | 0.19% | 2,158,394 | 238.37M |
| 408 | AMPH | Amphastar Pharmaceuticals, Inc. | 825.42M | -1.58% | 311,036 | 720.53M |
| 409 | OCS | Oculis Holding AG | 823.09M | -0.51% | 201,537 | 1.40M |
| 410 | HSTM | HealthStream, Inc. | 820.36M | 0.21% | 155,827 | 311.78M |
| 411 | ESPR | Esperion Therapeutics, Inc. | 819.46M | -0.31% | 32,784,984 | 418.24M |
| 412 | CTMX | CytomX Therapeutics, Inc. | 818.56M | -4.93% | 2,992,096 | 35.54M |
| 413 | CLYM | Climb Bio, Inc. | 801.65M | 1.30% | 1,254,119 | - |
| 414 | ODTX | Odyssey Therapeutics, Inc. | 799.08M | -0.83% | 619,527 | 1.06M |
| 415 | IMMX | Immix Biopharma, Inc. | 790.92M | 0.18% | 1,473,935 | - |
| 416 | NGNE | Neurogene Inc. | 789.70M | -7.49% | 290,565 | 925.00K |
| 417 | ZVRA | Zevra Therapeutics, Inc. | 789.19M | -4.23% | 2,060,243 | 122.29M |
| 418 | SPRY | ARS Pharmaceuticals, Inc. | 788.47M | 0.76% | 1,397,482 | 98.99M |
| 419 | RIGL | Rigel Pharmaceuticals, Inc. | 787.26M | -2.77% | 462,500 | 299.77M |
| 420 | ACRS | Aclaris Therapeutics, Inc. | 779.32M | -2.28% | 1,391,819 | 8.37M |
| 421 | SIBN | SI-BONE, Inc. | 778.77M | 0.80% | 421,141 | 206.22M |
| 422 | SLBT | SL Science Holding Limited | 764.49M | 3.73% | 110,039 | - |
| 423 | BBNX | Beta Bionics, Inc. | 758.89M | 3.65% | 1,060,498 | 110.24M |
| 424 | SSII | SS Innovations International, Inc. | 758.50M | 0.26% | 58,229 | 48.47M |
| 425 | DRUG | Bright Minds Biosciences Inc. | 754.68M | -0.46% | 331,431 | - |
| 426 | AURA | Aura Biosciences, Inc. | 754.45M | -2.29% | 442,809 | - |
| 427 | SGP | SpyGlass Pharma, Inc. | 752.92M | 12.21% | 169,472 | - |
| 428 | OMER | Omeros Corporation | 744.02M | 0.10% | 1,090,256 | 9.89M |
| 429 | CBLL | CeriBell, Inc. | 742.16M | -0.41% | 197,195 | 95.07M |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 735.82M | -4.28% | 2,447,126 | 361.51M |
| 431 | GYRE | Gyre Therapeutics, Inc. | 726.91M | -4.96% | 67,004 | 117.05M |
| 432 | RGNX | REGENXBIO Inc. | 721.20M | -10.86% | 3,226,823 | 87.82M |
| 433 | CSTL | Castle Biosciences, Inc. | 719.43M | -3.42% | 207,334 | 339.92M |
| 434 | MNPR | Monopar Therapeutics Inc. | 714.09M | 2.01% | 149,261 | - |
| 435 | CADL | Candel Therapeutics, Inc. | 695.33M | -4.04% | 1,063,451 | - |
| 436 | ALLO | Allogene Therapeutics, Inc. | 690.31M | -4.76% | 7,764,747 | 22.00K |
| 437 | PRME | Prime Medicine, Inc. | 682.73M | -10.64% | 6,653,541 | 4.03M |
| 438 | TCMD | Tactile Systems Technology, Inc. | 672.85M | -2.77% | 274,876 | 343.52M |
| 439 | RLMD | Relmada Therapeutics, Inc. | 672.35M | -1.54% | 1,444,730 | - |
| 440 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 666.49M | -8.47% | 389,512 | - |
| 441 | PHR | Phreesia, Inc. | 662.62M | -0.92% | 521,242 | 495.59M |
| 442 | EVH | Evolent Health, Inc. | 661.39M | 4.44% | 1,269,766 | 1.89B |
| 443 | CRMD | CorMedix Inc. | 659.00M | -3.11% | 807,647 | 400.05M |
| 444 | TECX | Tectonic Therapeutic, Inc. | 648.53M | -2.55% | 100,567 | - |
| 445 | AGMB | AgomAb Therapeutics NV | 644.16M | 0.38% | 47,228 | - |
| 446 | FDMT | 4D Molecular Therapeutics, Inc. | 643.52M | -4.50% | 683,555 | 88.24M |
| 447 | ACHV | Achieve Life Sciences, Inc. | 627.25M | -4.53% | 2,050,608 | - |
| 448 | CERS | Cerus Corporation | 625.15M | -0.95% | 1,729,139 | 216.56M |
| 449 | MDXG | MiMedx Group, Inc. | 612.17M | -0.72% | 670,183 | 389.42M |
| 450 | BWAY | BrainsWay Ltd. | 602.26M | -0.20% | 46,421 | 56.22M |
| 451 | CTKB | Cytek Biosciences, Inc. | 596.64M | 0.65% | 788,292 | 204.17M |
| 452 | DNA | Ginkgo Bioworks Holdings, Inc. | 593.80M | -6.58% | 1,085,057 | 151.40M |
| 453 | ALT | Altimmune, Inc. | 593.15M | -2.24% | 2,991,266 | 36.00K |
| 454 | TOI | The Oncology Institute, Inc. | 588.90M | 0.68% | 3,933,872 | 545.76M |
| 455 | FLGT | Fulgent Genetics, Inc. | 583.63M | -1.58% | 211,585 | 320.35M |
| 456 | NPCE | NeuroPace, Inc. | 583.34M | 0.82% | 179,513 | 99.53M |
| 457 | NVCT | Nuvectis Pharma, Inc. | 578.49M | -3.37% | 224,442 | - |
| 458 | CBIO | Crescent Biopharma, Inc. | 576.19M | 3.46% | 302,029 | 11.88M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 572.79M | -5.70% | 281,982 | - |
| 460 | CTNM | Contineum Therapeutics, Inc. | 567.90M | -1.68% | 279,310 | - |
| 461 | XOMA | XOMA Royalty Corporation | 554.56M | -1.29% | 295,648 | 48.56M |
| 462 | WEAV | Weave Communications, Inc. | 551.39M | 2.36% | 809,093 | 248.72M |
| 463 | MYGN | Myriad Genetics, Inc. | 550.63M | -4.43% | 856,979 | 829.00M |
| 464 | ASMB | Assembly Biosciences, Inc. | 542.99M | -1.69% | 169,991 | 71.10M |
| 465 | ARVN | Arvinas, Inc. | 533.59M | -3.16% | 423,161 | 89.40M |
| 466 | ANGO | AngioDynamics, Inc. | 533.11M | -1.01% | 202,940 | 313.73M |
| 467 | CTEV | Claritev Corporation | 532.57M | -5.05% | 60,331 | 978.76M |
| 468 | PROK | ProKidney Corp. | 531.62M | -2.22% | 936,859 | 889.00K |
| 469 | TLRY | Tilray Brands, Inc. | 527.23M | 0.68% | 3,130,121 | 858.28M |
| 470 | CLPT | ClearPoint Neuro, Inc. | 524.82M | -2.13% | 365,671 | 40.61M |
| 471 | KIDS | OrthoPediatrics Corp. | 522.18M | 0.49% | 57,326 | 243.30M |
| 472 | AQST | Aquestive Therapeutics, Inc. | 516.85M | -2.83% | 3,054,051 | 50.27M |
| 473 | KYTX | Kyverna Therapeutics, Inc. | 515.85M | -13.51% | 1,991,109 | - |
| 474 | STTK | Shattuck Labs, Inc. | 509.16M | -5.55% | 1,727,054 | 1.00M |
| 475 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 476 | EDIT | Editas Medicine, Inc. | 500.29M | -1.21% | 3,592,112 | 38.69M |
| 477 | OCGN | Ocugen, Inc. | 497.63M | - | 3,511,411 | 4.47M |
| 478 | RZLT | Rezolute, Inc. | 496.22M | -7.41% | 2,211,192 | - |
| 479 | STRO | Sutro Biopharma, Inc. | 492.64M | -0.87% | 242,434 | 99.61M |
| 480 | NRC | NRC Health | 487.92M | -0.28% | 87,324 | 138.64M |
| 481 | VSTM | Verastem, Inc. | 485.94M | 2.41% | 2,582,245 | 49.59M |
| 482 | ZURA | Zura Bio Limited | 485.44M | -7.26% | 1,254,557 | - |
| 483 | CABA | Cabaletta Bio, Inc. | 485.09M | -4.49% | 6,377,728 | - |
| 484 | PACB | Pacific Biosciences of California, Inc. | 484.54M | -3.11% | 6,685,144 | 160.03M |
| 485 | PRTA | Prothena Corporation plc | 483.74M | -4.15% | 505,129 | 57.94M |
| 486 | CYH | Community Health Systems, Inc. | 483.57M | -3.51% | 840,736 | 12.29B |
| 487 | PRLD | Prelude Therapeutics Incorporated | 476.55M | -2.14% | 577,888 | 16.72M |
| 488 | EVMN | Evommune, Inc. | 475.80M | -2.22% | 527,958 | 10.00M |
| 489 | SOPH | SOPHiA GENETICS SA | 474.01M | -2.92% | 314,363 | 81.18M |
| 490 | VALN | Valneva SE | 472.44M | -4.63% | 16,116 | 180.25M |
| 491 | VMD | Viemed Healthcare, Inc. | 471.93M | 0.41% | 236,527 | 286.57M |
| 492 | OVID | Ovid Therapeutics Inc. | 470.33M | -3.08% | 1,394,125 | 7.12M |
| 493 | OFIX | Orthofix Medical Inc. | 470.10M | 1.31% | 216,301 | 825.37M |
| 494 | ARTV | Artiva Biotherapeutics, Inc. | 468.39M | 2.44% | 442,028 | 251.00K |
| 495 | VREX | Varex Imaging Corporation | 465.72M | 2.60% | 311,939 | 857.50M |
| 496 | BNTC | Benitec Biopharma Inc. | 461.04M | -0.45% | 84,568 | - |
| 497 | SGMT | Sagimet Biosciences Inc. | 455.11M | 0.27% | 1,113,089 | - |
| 498 | EPRX | Eupraxia Pharmaceuticals Inc. | 451.89M | -3.33% | 245,316 | - |
| 499 | DCTH | Delcath Systems, Inc. | 449.13M | -3.77% | 294,488 | 90.44M |
| 500 | CCCC | C4 Therapeutics, Inc. | 448.90M | -5.36% | 2,582,982 | 34.86M |